Johnson & Johnson Ordered To Pay 707 Crore

J&J asked to pay ₹707cr to woman who blamed cancer on powder
Johnson & Johnson has been ordered to pay over $110 million (₹707 crore) to a woman who blamed her ovarian cancer on its talcum products. The woman used J&J’s baby powder and Shower to Shower talc products for 40 years before her diagnosis in 2012. Over 3,000 lawsuits have accused J&J of ignoring studies linking its products to ovarian cancer.

Johnson & Johnson changed into ordered by way of a St. Louis jury to pay extra than $110 million to a Virginia lady who blamed her ovarian cancer at the employer’s talcum products.

Imerys Talc America, which furnished the talc to J&J, turned into ordered by using the jury to pay approximately $100,000. Imerys Talc is a unit of Paris-based Imerys SA.

There are extra than 3,000 proceedings accusing the world’s largest fitness-care employer of ignoring studies linking its child powder and Shower to Shower talc products to ovarian cancer and failing to warn clients about the threat.

J&J lost jury verdicts of $72 million, $55 million and $70 million ultimate year, even as triumphing the first trial in 2017. J&J, based totally in New Brunswick, New Jersey, is attractive the trial losses. A New Jersey state court docket judge ultimate year threw out talc instances set for trial, locating insufficient medical guide for the claims. That decision is also on attraction.

J&J will appeal Thursday’s verdict, stated Carol Goodrich, a spokeswoman.